In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group
No matter which you chooseor if you decide to try bothlisten to your body and consult with a healthcare provider to find the best fit for your unique needs
Medicare currently covers GLP-1s for diabetes and other approved ailments such as obesity in conjunction with heart disease but is legally barred from covering the medication for weight loss alone
Prioritize Sleep Most testosterone production in men happens during deep sleep
You can eat breakfast, lunch, and dinner normally on injection day without compromising medication performance
A rapid transit time can cause green poop due to bile not being fully broken down
